| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/07/2007 | US7253203 Indoline derivatives |
| 08/07/2007 | US7253202 Substituted benzodioxepines |
| 08/07/2007 | US7253201 Small molecule inhibitors of necrosis |
| 08/07/2007 | US7253200 Using in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions |
| 08/07/2007 | US7253199 Azole derivatives and pharmaceutical compositions containing them |
| 08/07/2007 | US7253198 Hydroxyethylamine derivatives for the treatment of Alzheimer's disease |
| 08/07/2007 | US7253197 2-aryl- or heteroarylamino- 5-cycloalkanoyl-, aroyl-, or heteroaroyl- thiazoles; treatment or prophylaxis of obesity, especially in combination with orlistat. |
| 08/07/2007 | US7253196 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| 08/07/2007 | US7253195 Therapy for Alzheimer's disease, brain disorders, amyloidosis, multiple sclerosis, Down's syndrome |
| 08/07/2007 | US7253194 Compounds and inhibitors of phospholipases |
| 08/07/2007 | US7253193 Pyridyl cyanoguanidine compounds, e.g., 1-[2-(4-Piperidyl)-ethoxy-carbonyloxymethyl]-4-[N'-cyano-N''-(6-(4-chloro-phenoxy)-1-hexyl)-N-guanidino]-pyridinium chloride, hydrochloride; human and veterinary therapy of proliferative diseases such as cancers |
| 08/07/2007 | US7253192 Phenyl derivatives comprising an acetylene group |
| 08/07/2007 | US7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/07/2007 | US7253190 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 08/07/2007 | US7253189 1-aminoindane derivatives, e.g., 1-(cyclopentylcarbonylamino)-5-(4-cyclopropyl-2-(phenylsulfonyl)phenylsulfonyl)indane; exhibit anti-inflammatory and immunomodulatory activity |
| 08/07/2007 | US7253188 Aminobenzamide derivative |
| 08/07/2007 | US7253187 Heterocyclic inhibitors of ERK2 and uses thereof |
| 08/07/2007 | US7253186 N-substituted piperidine derivatives as serotonin receptor agents |
| 08/07/2007 | US7253185 Amino ceramide-like compounds and therapeutic methods of use |
| 08/07/2007 | US7253184 4-Phenoxyanilino-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes |
| 08/07/2007 | US7253183 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 08/07/2007 | US7253182 Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments |
| 08/07/2007 | US7253181 β3 adrenergic agonists |
| 08/07/2007 | US7253180 Viricides; immunology moderator |
| 08/07/2007 | US7253179 pyrido[4,3-b]carbazol derivatives; melanin-concentrating hormone (MCH) and somatostatin receptors modulator; eating disorders; obesity; anxiolytic agents; psychological disorders |
| 08/07/2007 | US7253178 Carboxylic acids |
| 08/07/2007 | US7253177 Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives |
| 08/07/2007 | US7253176 8-Thienyl- or furanyl-substituted xanthines in unit dosage form, optionally also containing cyclosporin A, tacrolimus, rapamycin, leflunomide or mofetil. |
| 08/07/2007 | US7253175 Orally or topically administering acyclovir, valacyclovir, famciclovir, penciclovir or ganciclovir, especially valacyclovir hydrochloride to treat fungal infections |
| 08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
| 08/07/2007 | US7253173 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents |
| 08/07/2007 | US7253170 Pyrazole-amine compounds useful as kinase inhibitors |
| 08/07/2007 | US7253169 Aza compounds, pharmaceutical compositions and methods of use |
| 08/07/2007 | US7253168 Substituted 1-benzyl-4-substituted piperazine analogues |
| 08/07/2007 | US7253167 Tricyclic-heteroaryl compounds useful as kinase inhibitors |
| 08/07/2007 | US7253166 6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells |
| 08/07/2007 | US7253165 Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists |
| 08/07/2007 | US7253164 1,4-benzothiazin-3-one derivatives that are optionally S-mono- or dioxygenated; peptide deformylase inhibitors, used for treating bacterial infections |
| 08/07/2007 | US7253163 Benzothiazine and benzothiadiazine compounds |
| 08/07/2007 | US7253162 Alzheimer's disease; cognition activators; central nervous system disorders |
| 08/07/2007 | US7253161 Cognition activators; neurodegenerative disease; anxiolytic agents; Alzheimer's diseas; Pick's disease; schizophrenia; psychological disorders; antiischemic agents; antiepileptic agents; antidepressants |
| 08/07/2007 | US7253160 Depeptidized inhibitors of hepatitis C virus NS3 protease |
| 08/07/2007 | US7253159 Antigen and lysine acylated protein; cytokines; drug screening; liquid chromatography |
| 08/07/2007 | US7253158 Sulfonamides |
| 08/07/2007 | US7253157 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 08/07/2007 | US7253156 E.g., budesonide dodecylcarbonate and budesonide 2-dimethylaminoethyl carbonatewith agonists such as albuterol, formoterol, or salmeterol; used for inducing bronchodilation and treating COPD, asthma and rhinitis. |
| 08/07/2007 | US7253155 Combination of a tetra-substituted pyrimidopyrimidine, and a corticosteroid simultaneously or within 14 days of each other |
| 08/07/2007 | US7253154 Substituted thiazolopyrimidines as xanthine oxidase inhibitors |
| 08/07/2007 | US7253153 Brain disorders; antiischemic agents; antiepileptic agents; cardiovascular disorders; vision defects; spinal cord injuries; psychological disorders; anxiolytic agents; schizophrenia |
| 08/07/2007 | US7253152 Electrically conductive polymeric biomaterials, the process for their preparation and the use thereof in the biomedical and healthcare field |
| 08/07/2007 | US7253151 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 08/07/2007 | US7253150 Gene delivery vehicle expressing the aptosis-inducing proteins VP2 and/or apoptin |
| 08/07/2007 | US7252974 Human growth gene and short stature gene region |
| 08/07/2007 | US7252845 Synergistic compositions containing aromatic compounds and terpenoids present in Alpinia galanga |
| 08/07/2007 | US7252842 Encapsulation of hydrophilic active agents in biodegradable polymers; employs a minimal volume of surfactant solution resulting in a reduced production time |
| 08/07/2007 | US7252835 Administering 4-oxo-8-(4-(4- phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl )4H-1-benzopyran or salt or hydrate for therapy of sinusitis |
| 08/07/2007 | US7252833 Calcium phosphate cements comprising an osteoclastogenic agent |
| 08/07/2007 | US7252828 For inducing active immunity to infections caused by Staphylococcus aureus, S. epidermidis |
| 08/07/2007 | US7252822 Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist |
| 08/07/2007 | US7252817 Administering viruses selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus to mammal having Ras-activated pathway to result in lysis of proliferating cells |
| 08/07/2007 | US7252654 Apparatus with weeping tip and method of use |
| 08/07/2007 | CA2802892A1 Composition for preventing recurrence of stroke |
| 08/07/2007 | CA2730485A1 Divalent metal ion sensors and binders |
| 08/07/2007 | CA2571462A1 Composition for preventing recurrence of stroke |
| 08/07/2007 | CA2470124C Process for preparing 10-desacetylbaccatine iii |
| 08/07/2007 | CA2434655C Cubic liquid crystalline phase precursor |
| 08/07/2007 | CA2407952C Growth factor modified protein matrices for tissue engineering |
| 08/07/2007 | CA2365832C Pharmacological screening of neuronally active substances |
| 08/07/2007 | CA2361392C Premixed formulation of piperacillin sodium and tazobactam sodium injection |
| 08/07/2007 | CA2351536C Therapeutic anti-fungal nail preparation |
| 08/07/2007 | CA2340636C Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 08/07/2007 | CA2333938C New 3-aryl-2-hydroxypropionic acid derivative (i) |
| 08/07/2007 | CA2332007C Adenosine a3 receptor modulators |
| 08/07/2007 | CA2327775C 15-membered lactams ketolides with antibacterial activity |
| 08/07/2007 | CA2326840C Carvedilol-galenics |
| 08/07/2007 | CA2325842C Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof |
| 08/07/2007 | CA2324887C Ophthalmic composition comprising a .beta.-blocker |
| 08/07/2007 | CA2324001C Retinoid-like compounds for the promotion of melanin production |
| 08/07/2007 | CA2317589C Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 08/07/2007 | CA2316981C Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| 08/07/2007 | CA2315397C Arylthiazolidinedione derivatives |
| 08/07/2007 | CA2302943C Phthalazine compounds and therapeutic agents for erectile dysfunction |
| 08/07/2007 | CA2286304C Pca3, pca3 genes, and methods of use |
| 08/07/2007 | CA2281946C Pharmaceutical formulations containing poorly soluble drug substances |
| 08/07/2007 | CA2271657C Androgen as a male contraceptive and non-contraceptive androgen replacement |
| 08/07/2007 | CA2270955C Pharmaceutical composition containing morphinan derivative for treating drug dependence |
| 08/07/2007 | CA2266533C Pharmaceutical compositions comprising s-alkylisothiouronium derivatives |
| 08/07/2007 | CA2263904C Process to obtain oestrogens from mare's urine |
| 08/07/2007 | CA2247734C New piperazine and piperidine compounds selectively binding dopamine and serotonin receptors |
| 08/07/2007 | CA2244679C Tranilast-containing preparation for external application and method of producing the same |
| 08/07/2007 | CA2239702C Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 08/07/2007 | CA2234282C Drug-resin complexes stabilized by chelating agents |
| 08/07/2007 | CA2221689C Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
| 08/07/2007 | CA2207804C Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
| 08/07/2007 | CA2192360C Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme |
| 08/07/2007 | CA2184842C New stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
| 08/07/2007 | CA2182388C Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy |
| 08/07/2007 | CA2132265C Anti-sense oligonucleotides against hsv-1, and their preparation |